Ameridose Recalls Products

    Two men stand guard outside the entrance to Ameridose LLC in Westborough, Mass., Thursday Oct. 11, 2012, a separate pharmaceutical firm with common ownership of New England Compounding Center, the source of steroid shots suspected in the outbreak of rare fungal meningitis. Ameridose LLC has agreed to temporarily stop its compounding and manufacturing operations as a precaution while regulators inspect its facilities, but the measure is being taken as a precaution, not because of evidence of contamination, officials said. Ameridose was accused by a business customer this year of failing to separate sterile and non-sterile products in its warehouse, charges it vehemently denied. (AP Photo/Elise Amendola)

    Elise Amendola / AP Photo

    A second pharmaceutical company is recalling all of its products in the wake of the meningitis outbreak that has killed almost 30 people. Massachusetts-based Ameridose is voluntarily participating in the recall, but says it hasn’t received any reports of problems with its medications. Ameridose and the New England Compounding Center, which earlier this year manufactured steroids contaminated with fungus, are owned by the same group. The Food and Drug Administration has asked Ameridose to improve its sterility testing process. The move may create some drug shortages, and the FDA is working with other companies to fill the supply gap.

    Read it at Reuters